Skip to main content

Table 1 Baseline characteristics of pregnant women with malaria episode Nchelenge, Zambia (2010–2014)

From: Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria

  AL (N = 300) MQAS (N = 300) DHAPQ (N = 300)
Age (years): median (IQR) 20 (18–24) 19 (18–24) 20 (18–24)
Symptomatic malaria (%) 46.0 48.7 52.7
 Fever (temperature ≥ 37.5 °C) (%) 2.0 3.3 3.7
 Parasite density >2000/µL (%) 41.0 42.7 45.7
 At least 3 symptomsa (%) 11.0 12.3 12.0
Gametocytes present (%) 2.3 0 1.3
Parasite density (/µL): median (IQR) 1360 (480–4280) 1610 (540–4340) 1640 (520–4880)
Haemoglobin (g/dL): median (IQR) 10.0 (9.1–11.0) 10.0 (9.0–10.9) 10.0 (9.2–10.9)
Gravidity
 1st Pregnancy (%) 33.3 35.7 31.3
 2nd Pregnancy (%) 30.3 30.3 32.0
 3rd Pregnancy or more (%) 36.3 34.0 36.7
Gestational ageb
 2nd Trimester (%) 50.0 50.0 43.7
 3rd Trimester (%) 50.0 50.0 56.3
Bed net used before study entry (%) 30.7 28.7 27.3
ITN used before study entryc (%) 25.3 21.0 22.7
 IPT use (before day 0) (%) 9.7 7.0 11.7
  1. aAt least 3 or more of the following symptoms: fever in the past 24 h, weakness/fatigue; muscle and/or joint aches, headache, convulsion, with parasitaemia of any density
  2. b2nd Trimester were patients ≤24 weeks gestation and 3rd trimester >24 weeks gestation
  3. cWomen were provided with ITN at study start